JARED WALSH, M.D.
Addiction Medicine (Internal Medicine) Physician in NEWARK, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
JARED WALSH, M.D. reported a CMS MIPS final score of 73.2773/100 — below the 83.1 national average — and filed 1,246 Medicare Part D claims in 2023.
- 73.2773/100
- MIPS score · -10 vs avg
- 1K
- Part D claims, 2023
- 87%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
JARED WALSH, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
73 11th percentile higher than 11% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
JARED WALSH, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about JARED WALSH, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Jersey
How Addiction Medicine (Internal Medicine) Physician compares to other specialties among New Jersey providers
Addiction Medicine (Internal Medicine) Physician share within New Jersey
Addiction Medicine (Internal Medicine) Physician is one of the more visible NUCC categories in New Jersey
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
JARED WALSH, M.D.'s 2023 MIPS final score plotted against the Addiction Medicine (Internal Medicine) Physician national average
- MIPS Final Score
- 73.2773/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Addiction Medicine (Internal Medicine) Physician) — 73.2773/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Addiction Medicine (Internal Medicine) Physician US NPIs
73.2773/100 MIPS final score — 9.8 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Addiction Medicine (Internal Medicine) Physician. Quality dim: 44.8928. Cost dim: 47.6995.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JARED WALSH, M.D. appears in the CMS NPPES registry as a Addiction Medicine (Internal Medicine) Physician provider holding M.D. credentials at 90 BERGEN ST STE 4200, NEWARK, NJ, 07103, with a listed phone of (973) 972-5672. NPI 1619395274 was issued on 04/01/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WALSH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,246 prescription claims written by this provider, covering 196 Medicare beneficiaries and totaling roughly $162K in drug spend, split 13% brand-name and 87% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 73.2773/100 for the 2023 performance year (Quality 44.8928, Cost 47.6995), compared with the national average of 83.1.
Addiction Medicine (Internal Medicine) Physician is a narrow specialty nationwide, with 553 enrolled providers across 46 states and an average of 1,403 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1619395274 |
|---|---|
| Specialty | Addiction Medicine (Internal Medicine) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/01/2014 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JARED WALSH, M.D.'s current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where JARED WALSH, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
13% brand-name claims vs 87% generic, on 1,246 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,260
- Total Day Supply
- 64,810
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $122K
- Generic Drug Cost
- $39K
Patient Demographics
- Average Patient Age
- 68.9 years
- Avg HCC Risk Score
- 1.67
- Gender Split
- 52% female / 48% male
- Age Distribution
- <65: 52, 65-74: 88, 75-84: 39, 85+: 17
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What JARED WALSH, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Amlodipine Besylate
Amlodipine Besylate
80 claims
- Atorvastatin Calcium
Atorvastatin Calcium
69 claims
- Diclofenac Sodium
Diclofenac Sodium
55 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
54 claims
- Buprenorphine-Nalo…
Buprenorphine-Naloxone
47 claims
- Lisinopril
Lisinopril
42 claims
- Losartan Potassium
Losartan Potassium
39 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
38 claims
| Drug | Claims |
|---|---|
| Amlodipine Besylate | 80 |
| Atorvastatin Calcium | 69 |
| Diclofenac Sodium | 55 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 54 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 47 |
| Lisinopril | 42 |
| Losartan Potassium | 39 |
| Rosuvastatin Calcium | 38 |
| Gabapentin | 37 |
| Hydrochlorothiazide | 36 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Addiction Medicine (Internal Medicine) Physician Overview
How JARED WALSH, M.D. fits within the Addiction Medicine (Internal Medicine) Physician landscape nationally.
JARED WALSH, M.D.'s 1,246 claims are below the specialty average of 1,403.
Nearby Addiction Medicine (Internal Medicine) Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as WALSH.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is JARED WALSH, M.D.'s specialty? ▼
How much does JARED WALSH, M.D. prescribe under Medicare Part D? ▼
What is JARED WALSH, M.D.'s Medicare quality score? ▼
Where is JARED WALSH, M.D. located? ▼
What is JARED WALSH, M.D.'s NPI number? ▼
Does JARED WALSH, M.D. prescribe more brand-name or generic drugs? ▼
How many Addiction Medicine (Internal Medicine) Physician providers are there in the US? ▼
What drugs does JARED WALSH, M.D. prescribe most often? ▼
Does JARED WALSH, M.D. accept Medicare? ▼
How can I verify JARED WALSH, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology